Mallinckrodt has filed a patent for a valve assembly with a housing, valve, indexed members, and a radio frequency identification device. The assembly is designed to align with a canister, seal it, and open with a single movement. The patent also covers a drug containment device with this valve assembly. GlobalData’s report on Mallinckrodt gives a 360-degree view of the company including its patenting strategy. Buy the report here.

Smarter leaders trust GlobalData


Data Insights Mallinckrodt Plc - Company Profile

Buy the Report

Data Insights

The gold standard of business intelligence.

Find out more

According to GlobalData’s company profile on Mallinckrodt, was a key innovation area identified from patents. Mallinckrodt‘s grant share as of January 2024 was 55%. Grant share is based on the ratio of number of grants to total number of patents.

Valve assembly for drug containment with radio frequency identification

Source: United States Patent and Trademark Office (USPTO). Credit: Mallinckrodt Plc

The patent application (Publication Number: US20240017035A1) describes a valve assembly and a drug containment device designed for pharmaceutical applications. The valve assembly includes a housing, a valve, and a radio frequency identification device that communicates with a receiver. The valve is specifically designed to align with a canister, seal it, and open in a single movement, providing efficient and secure containment for pharmaceutical substances.

In addition to the valve assembly, the drug containment device comprises a canister containing an active pharmaceutical ingredient, further enhancing the secure storage and delivery of pharmaceutical substances. The device also includes indexed members that indicate the identity and concentration of the active ingredient, ensuring accurate and reliable pharmaceutical management. The incorporation of a radio frequency identification device adds an additional layer of security and traceability by communicating identifying information to a receiver. Overall, these innovations aim to streamline the handling and administration of pharmaceuticals, particularly substances like nitric oxide, carbon monoxide, and chalcogenide compounds, within specific concentration ranges.

To know more about GlobalData’s detailed insights on Mallinckrodt, buy the report here.

Data Insights


The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.


GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies